Search - tctmd.com

Displaying 21 - 40 of 273

Sort: Relevancy | Date

Presentation TCT 2020

TRANSIT: Treatment of Failed TAVR With TAVR

Presenter: Luca Testa

October 17, 2020

Presentation TCT 2020

SCOPE I: One-year outcomes of a randomized trial comparing a self-expanding to a balloon-expandable transcatheter aortic valve

Presenter: Thomas Walther

October 17, 2020

News Conference News TCT 2020

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

Shelley Wood

October 16, 2020

News Conference News TCT 2020

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Michael O'Riordan

October 16, 2020

Presentation TCT 2020

Cerebral Embolic Protection and TAVR Outcomes: Results from the TVT Registry

Presenter: David Cohen

October 16, 2020

News Conference News TCT 2020

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

Todd Neale

October 16, 2020

A 2x2 Randomized Trial of Self-Expandable vs Balloon-Expandable Valves and General vs Local Anesthesia in Patients Undergoing Transcatheter Aortic Valve Implantation: 1-year Results

Presentation TCT 2020

SOLVE TAV - A 2x2 Randomized Trial of Self-Expandable vs Balloon-Expandable Valves and General vs Local Anesthesia in Patients Undergoing Transcatheter Aortic Valve Implantation: 1-year Results

Presenter: Hans-Josef Feistritzer

October 16, 2020

Presentation TCT 2020

TAVR in Aortic Bioprosthetic Valve Failure - Thoughtful Perspectives From a Surgeon on Valve-in-Valve TAVR

Presenter: Michael Mack

October 16, 2020

Presentation TCT 2020

TCT ID 6: Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement

Presenter: Michael Megaly

October 15, 2020

News Conference News TCT 2020

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Shelley Wood

October 15, 2020

Presentation TCT 2020

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Presenter: Jeffrey W. Moses

October 15, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

News Conference News TCT 2020

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Todd Neale

October 15, 2020

Presentation TCT 2020

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Presenter: Corrado Tamburino

October 15, 2020

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Caitlin E. Cox

October 14, 2020

Presentation TCT 2020

Importance of Prosthesis-Patient Mismatch After TAVR: Definitions, Incidence, and Clinical Relevance

Presenter: Dee Dee Wang

October 14, 2020

Presentation TCT 2020

TCT 679: Inside Out: Left Ventricular Aneurysm Following Transcatheter Aortic Valve Replacement.

Presenter: Sebastian Carrasquillo

October 14, 2020

Presentation TCT 2020

TCT 666: Emergent TAVR as Rescue Therapy in Valvular Cardiogenic Shock

Presenter: Alexander Smith

October 14, 2020

Presentation TCT 2020

TCT 654: TAVR (Aortic Valve-in-Valve) in Post Bentall Procedure Patient

Presenter: Manik Chopra

October 14, 2020

Presentation TCT 2020

TCT 618: First Human Transcatheter Aortic Valve Implantation of the Colibri Heart Valve, a Pre-Mounted, Pre-Packaged, Low Profile Dry Valve: a 7-Year Follow-Up

Presenter: Leslie Ammabel Ynalvez

October 14, 2020

Advertisement

TRANSIT: Treatment of Failed TAVR With TAVR

SCOPE I: One-year outcomes of a randomized trial comparing a self-expanding to a balloon-expandable transcatheter aortic valve

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Cerebral Embolic Protection and TAVR Outcomes: Results from the TVT Registry

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

SOLVE TAV - A 2x2 Randomized Trial of Self-Expandable vs Balloon-Expandable Valves and General vs Local Anesthesia in Patients Undergoing Transcatheter Aortic Valve Implantation: 1-year Results

TAVR in Aortic Bioprosthetic Valve Failure - Thoughtful Perspectives From a Surgeon on Valve-in-Valve TAVR

TCT ID 6: Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Importance of Prosthesis-Patient Mismatch After TAVR: Definitions, Incidence, and Clinical Relevance

TCT 679: Inside Out: Left Ventricular Aneurysm Following Transcatheter Aortic Valve Replacement.

TCT 666: Emergent TAVR as Rescue Therapy in Valvular Cardiogenic Shock

TCT 654: TAVR (Aortic Valve-in-Valve) in Post Bentall Procedure Patient

TCT 618: First Human Transcatheter Aortic Valve Implantation of the Colibri Heart Valve, a Pre-Mounted, Pre-Packaged, Low Profile Dry Valve: a 7-Year Follow-Up

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content